Cargando…
Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality
Objectives: The European Society of Cardiology endorsed SCORE2 to assess cardiovascular risk. The aim of this observational, retrospective study was to assess whether SCORE2 is associated with colorectal neoplasia in an asymptomatic screening population. Further, we evaluated if SCORE2 predicts tumo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146398/ https://www.ncbi.nlm.nih.gov/pubmed/35629269 http://dx.doi.org/10.3390/jpm12050848 |
_version_ | 1784716554164764672 |
---|---|
author | Wernly, Sarah Semmler, Georg Völkerer, Andreas Rezar, Richard Datz, Leonora Radzikowski, Konrad Stickel, Felix Aigner, Elmar Niederseer, David Wernly, Bernhard Datz, Christian |
author_facet | Wernly, Sarah Semmler, Georg Völkerer, Andreas Rezar, Richard Datz, Leonora Radzikowski, Konrad Stickel, Felix Aigner, Elmar Niederseer, David Wernly, Bernhard Datz, Christian |
author_sort | Wernly, Sarah |
collection | PubMed |
description | Objectives: The European Society of Cardiology endorsed SCORE2 to assess cardiovascular risk. The aim of this observational, retrospective study was to assess whether SCORE2 is associated with colorectal neoplasia in an asymptomatic screening population. Further, we evaluated if SCORE2 predicts tumor-related mortality. Methods: We included 3408 asymptomatic patients who underwent a screening colonoscopy. We calculated SCORE2 for each participant and stratified patients according to their predicted 10-year risk of cardiovascular disease: SCORE2 0–4.9%, SCORE2 5–9.9%, and SCORE2 ≥ 10%. We assessed the association between SCORE2 as a continuous variable, the presence of colorectal neoplasia using multilevel logistic regression, and SCORE2 and mortality using Cox regression. Results: In total, 1537 patients had a SCORE2 of 0–4.9%, 1235 a SCORE2 of 5–9.9%, and 636 a SCORE2 ≥ 10%. The respective rates of colorectal neoplasia were 20%, 37%, and 44%. SCORE2 was associated with the presence of any (OR 1.11 95%CI 1.09–1.12; p < 0.001) and advanced colorectal neoplasia (OR 1.06 95%CI 1.08–1.13; p < 0.001) in univariate analysis. After multivariable adjustment (age, sex, family history, and metabolic syndrome) a higher SCORE2 remained associated with higher odds for any (aOR 1.04 95%CI 1.02–1.06; p = 0.001) and advanced (aOR 1.06 95%CI 1.03–1.10; p < 0.001) colorectal neoplasia. SCORE2 was associated with both all-cause (HR 1.11 95%CI 1.09–1.14; p < 0.001) and tumor-related mortality (HR 1.10 95%CI 1.05–1.14; p < 0.001). Conclusions: We found that SCORE2 is associated with the presence of colorectal neoplasia. Clinicians could kill two birds with one stone calculating SCORE2. In patients with a high SCORE2, screening colonoscopy aside from cardiovascular risk mitigation could improve outcomes. |
format | Online Article Text |
id | pubmed-9146398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91463982022-05-29 Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality Wernly, Sarah Semmler, Georg Völkerer, Andreas Rezar, Richard Datz, Leonora Radzikowski, Konrad Stickel, Felix Aigner, Elmar Niederseer, David Wernly, Bernhard Datz, Christian J Pers Med Article Objectives: The European Society of Cardiology endorsed SCORE2 to assess cardiovascular risk. The aim of this observational, retrospective study was to assess whether SCORE2 is associated with colorectal neoplasia in an asymptomatic screening population. Further, we evaluated if SCORE2 predicts tumor-related mortality. Methods: We included 3408 asymptomatic patients who underwent a screening colonoscopy. We calculated SCORE2 for each participant and stratified patients according to their predicted 10-year risk of cardiovascular disease: SCORE2 0–4.9%, SCORE2 5–9.9%, and SCORE2 ≥ 10%. We assessed the association between SCORE2 as a continuous variable, the presence of colorectal neoplasia using multilevel logistic regression, and SCORE2 and mortality using Cox regression. Results: In total, 1537 patients had a SCORE2 of 0–4.9%, 1235 a SCORE2 of 5–9.9%, and 636 a SCORE2 ≥ 10%. The respective rates of colorectal neoplasia were 20%, 37%, and 44%. SCORE2 was associated with the presence of any (OR 1.11 95%CI 1.09–1.12; p < 0.001) and advanced colorectal neoplasia (OR 1.06 95%CI 1.08–1.13; p < 0.001) in univariate analysis. After multivariable adjustment (age, sex, family history, and metabolic syndrome) a higher SCORE2 remained associated with higher odds for any (aOR 1.04 95%CI 1.02–1.06; p = 0.001) and advanced (aOR 1.06 95%CI 1.03–1.10; p < 0.001) colorectal neoplasia. SCORE2 was associated with both all-cause (HR 1.11 95%CI 1.09–1.14; p < 0.001) and tumor-related mortality (HR 1.10 95%CI 1.05–1.14; p < 0.001). Conclusions: We found that SCORE2 is associated with the presence of colorectal neoplasia. Clinicians could kill two birds with one stone calculating SCORE2. In patients with a high SCORE2, screening colonoscopy aside from cardiovascular risk mitigation could improve outcomes. MDPI 2022-05-23 /pmc/articles/PMC9146398/ /pubmed/35629269 http://dx.doi.org/10.3390/jpm12050848 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wernly, Sarah Semmler, Georg Völkerer, Andreas Rezar, Richard Datz, Leonora Radzikowski, Konrad Stickel, Felix Aigner, Elmar Niederseer, David Wernly, Bernhard Datz, Christian Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title | Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title_full | Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title_fullStr | Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title_full_unstemmed | Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title_short | Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality |
title_sort | cardiovascular risk assessment by score2 predicts risk for colorectal neoplasia and tumor-related mortality |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146398/ https://www.ncbi.nlm.nih.gov/pubmed/35629269 http://dx.doi.org/10.3390/jpm12050848 |
work_keys_str_mv | AT wernlysarah cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT semmlergeorg cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT volkererandreas cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT rezarrichard cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT datzleonora cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT radzikowskikonrad cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT stickelfelix cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT aignerelmar cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT niederseerdavid cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT wernlybernhard cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality AT datzchristian cardiovascularriskassessmentbyscore2predictsriskforcolorectalneoplasiaandtumorrelatedmortality |